Pegylated Liposomal Doxorubicin and weekly paclitaxel as first line therapy in metastatic breast cancer

MLA

Fulfaro, Fabio, et al. Pegylated Liposomal Doxorubicin and Weekly Paclitaxel as First Line Therapy in Metastatic Breast Cancer. Jan. 2006. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......3658..d0be2ea1db6436c0ca1f0c11c570e774&authtype=sso&custid=ns315887.

APA

Fulfaro, F., Valerio Mr, & Cicero G. (2006). Pegylated Liposomal Doxorubicin and weekly paclitaxel as first line therapy in metastatic breast cancer.

Chicago

Fulfaro, Fabio, Valerio Mr, and Cicero G. 2006. “Pegylated Liposomal Doxorubicin and Weekly Paclitaxel as First Line Therapy in Metastatic Breast Cancer,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......3658..d0be2ea1db6436c0ca1f0c11c570e774&authtype=sso&custid=ns315887.